Literature DB >> 5461203

Human serum proinsulin.

F Melani, A H Rubenstein, D F Steiner.   

Abstract

Gel filtration of human serum extracts on Bio-Gel P-30 columns produced two peaks of material reactive with insulin antisera. The earlier eluting fraction appeared at the elution position of proinsulin (serum proinsulin-like component, PLC) while the second fraction corresponded in elution volume to insulin. In assays using porcine insulin-(131)I and an antiserum against porcine insulin, human pancreatic proinsulin was less reactive than human insulin. Serial dilutions of the serum PLC in the immunoassay showed immunological identity with the human proinsulin standard. Partial tryptic digestion of the serum PLC yielded products with increased immunological reactivity as estimated with insulin as the standard. With larger amounts of trypsin, all the serum PLC was converted to insulin-like components (desthreonine and desoctapeptide insulin). On the basis of these results we conclude that the earlier eluting fraction of human serum extracts is proinsulin. The fasting values of proinsulin in normal subjects ranged between 0.05 and 0.4 ng/ml, representing from 5 to 48% of the insulin concentration. In one subject the values of proinsulin were higher than those of insulin. After oral administration of 100 g of glucose, the proinsulin levels tended to rise similarly to insulin. Three obese patients with hyperinsulinemia had higher fasting levels of proinsulin and a greater increase after glucose than the normal subjects. As the high levels of proinsulin coexisted with raised insulin concentration in these obese subjects, the relative proportions of the two hormones were in the same range observed in the normal group. Thus hyperinsulinemia in these obese subjects was not accompanied by an increase in the fraction of serum proinsulin. When the values for serum proinsulin were expressed as percentage of the insulin levels, there was a decrease in the per cent proinsulin in the first hour of the glucose tolerance test. After the second hour, the per cent tended to rise towards the fasting levels.

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 5461203      PMCID: PMC322497          DOI: 10.1172/JCI106259

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  17 in total

1.  Immunologic aspects of insulin.

Authors:  R S YALOW; S A BERSON
Journal:  Am J Med       Date:  1961-12       Impact factor: 4.965

2.  Preparation of iodine-131 labelled human growth hormone of high specific activity.

Authors:  W M HUNTER; F C GREENWOOD
Journal:  Nature       Date:  1962-05-05       Impact factor: 49.962

3.  The biosynthesis of insulin and a probable precursor of insulin by a human islet cell adenoma.

Authors:  D F Steiner; P E Oyer
Journal:  Proc Natl Acad Sci U S A       Date:  1967-02       Impact factor: 11.205

4.  Physical studies on proinsulin-association behavior and conformation in solution.

Authors:  B H Frank; A J Veros
Journal:  Biochem Biophys Res Commun       Date:  1968-07-26       Impact factor: 3.575

5.  Circulating insulins. "Big" and "little".

Authors:  P Gorden; J Roth
Journal:  Arch Intern Med       Date:  1969-03

6.  Effect of porcine proinsulin in vitro on adipose tissue and diaphragm of the normal rat.

Authors:  W N Shaw; R E Chance
Journal:  Diabetes       Date:  1968-12       Impact factor: 9.461

7.  Separation of dansyl-amino acids by polyamide layer chromatography.

Authors:  K R Woods; K T Wang
Journal:  Biochim Biophys Acta       Date:  1967-02-21

8.  Electron microscopy of the pancreatic islets of the rat. Effects of prolonged insulin injections.

Authors:  J Logothetopoulos
Journal:  Diabetes       Date:  1966-11       Impact factor: 9.461

9.  Porcine proinsulin: characterization and amino acid sequence.

Authors:  R E Chance; R M Ellis; W W Bromer
Journal:  Science       Date:  1968-07-12       Impact factor: 47.728

Review 10.  Proinsulin and the biosynthesis of insulin.

Authors:  D F Steiner; J L Clark; C Nolan; A H Rubenstein; E Margoliash; B Aten; P E Oyer
Journal:  Recent Prog Horm Res       Date:  1969
View more
  35 in total

1.  The excretion of proinsulin and insulin in urine.

Authors:  L Constan; M Mako; D Juhn; A H Rubenstein
Journal:  Diabetologia       Date:  1975-04       Impact factor: 10.122

2.  Proinsulin, insulin, and C-peptide concentrations in human portal and peripheral blood.

Authors:  D L Horwitz; J I Starr; M E Mako; W G Blackard; A H Rubenstein
Journal:  J Clin Invest       Date:  1975-06       Impact factor: 14.808

Review 3.  [Proinsulin. Biosynthesis and secretion].

Authors:  F Melani
Journal:  Acta Diabetol Lat       Date:  1972 Jan-Feb

4.  A threshold distribution hypothesis for packet storage of insulin and its mathematical modeling.

Authors:  G M Grodsky
Journal:  J Clin Invest       Date:  1972-08       Impact factor: 14.808

5.  Biologically active circulating proinsulin-like materials from an islet cell carcinoma patient.

Authors:  N R Lazarus; R A Gutman; J C Penhos; L Recant
Journal:  Diabetologia       Date:  1972-04       Impact factor: 10.122

6.  Circulating proinsulin-like component in man: increased proportion in hypoinsulinemic states.

Authors:  P Gorden; C M Hendricks; J Roth
Journal:  Diabetologia       Date:  1974-10       Impact factor: 10.122

7.  Growth hormone and metasomatotrophic diabetes: effects on insulin and proinsulin of serum and pancreas in dogs.

Authors:  J Pierluissi; J Campbell
Journal:  Diabetologia       Date:  1981-12       Impact factor: 10.122

8.  Calcemic fraction-A: biosynthetic peptide precursor of parathyroid hormone.

Authors:  D V Cohn; R R Macgregor; L L Chu; J R Kimmel; J W Hamilton
Journal:  Proc Natl Acad Sci U S A       Date:  1972-06       Impact factor: 11.205

9.  Characterization of proinsulin-insulin intermediates in human plasma.

Authors:  C de Haën; S A Little; J M May; R H Williams
Journal:  J Clin Invest       Date:  1978-10       Impact factor: 14.808

10.  Hyperinsulinaemia in obesity is not accompanied by an increase in serum proinsulin/insulin ratio in groups of human subjects with and without glucose intolerance.

Authors:  I Shiraishi; Y Iwamoto; T Kuzuya; A Matsuda; S Kumakura
Journal:  Diabetologia       Date:  1991-10       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.